Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon Cancer Predicts a Poor Prognosis

<div>The prognosis value of IGF2BP3 expression. (a, b) Kaplan-Meier survival curves of IGF2BP3 expression and prognosis in TCGA and the GSE 41258 dataset; (c, d) univariate and multivariate Cox regression analyses of IGF2BP3 expression in TCGA.</div>

Disease Markers

fig4

Figure 4

Figure 4: Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon Cancer Predicts a Poor Prognosis 